222 related articles for article (PubMed ID: 35632738)
1. High Expression of HERV-K (HML-2) Might Stimulate Interferon in COVID-19 Patients.
Guo Y; Yang C; Liu Y; Li T; Li H; Han J; Jia L; Wang X; Zhang B; Li J; Li L
Viruses; 2022 May; 14(5):. PubMed ID: 35632738
[No Abstract] [Full Text] [Related]
2. Significant Upregulation of HERV-K (HML-2) Transcription Levels in Human Lung Cancer and Cancer Cells.
Yang C; Guo X; Li J; Han J; Jia L; Wen HL; Sun C; Wang X; Zhang B; Li J; Chi Y; An T; Wang Y; Wang Z; Li H; Li L
Front Microbiol; 2022; 13():850444. PubMed ID: 35359739
[TBL] [Abstract][Full Text] [Related]
3. Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals.
Contreras-Galindo R; Kaplan MH; Markovitz DM; Lorenzo E; Yamamura Y
AIDS Res Hum Retroviruses; 2006 Oct; 22(10):979-84. PubMed ID: 17067267
[TBL] [Abstract][Full Text] [Related]
4. Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers.
de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF; Michaud HA
Retrovirology; 2017 Aug; 14(1):41. PubMed ID: 28830571
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 in Children: Expressions of Type I/II/III Interferons, TRIM28, SETDB1, and Endogenous Retroviruses in Mild and Severe Cases.
Tovo PA; Garazzino S; Daprà V; Pruccoli G; Calvi C; Mignone F; Alliaudi C; Denina M; Scolfaro C; Zoppo M; Licciardi F; Ramenghi U; Galliano I; Bergallo M
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299101
[TBL] [Abstract][Full Text] [Related]
6. Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals.
Contreras-Galindo R; Kaplan MH; Contreras-Galindo AC; Gonzalez-Hernandez MJ; Ferlenghi I; Giusti F; Lorenzo E; Gitlin SD; Dosik MH; Yamamura Y; Markovitz DM
J Virol; 2012 Jan; 86(1):262-76. PubMed ID: 22031938
[TBL] [Abstract][Full Text] [Related]
7. Expression of Human Endogenous Retrovirus Group K (HERV-K) HML-2 Correlates with Immune Activation of Macrophages and Type I Interferon Response.
Russ E; Mikhalkevich N; Iordanskiy S
Microbiol Spectr; 2023 Mar; 11(2):e0443822. PubMed ID: 36861980
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Infection of Primary CD4
Young GR; Terry SN; Manganaro L; Cuesta-Dominguez A; Deikus G; Bernal-Rubio D; Campisi L; Fernandez-Sesma A; Sebra R; Simon V; Mulder LCF
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046457
[TBL] [Abstract][Full Text] [Related]
9. HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.
Jones RB; Garrison KE; Mujib S; Mihajlovic V; Aidarus N; Hunter DV; Martin E; John VM; Zhan W; Faruk NF; Gyenes G; Sheppard NC; Priumboom-Brees IM; Goodwin DA; Chen L; Rieger M; Muscat-King S; Loudon PT; Stanley C; Holditch SJ; Wong JC; Clayton K; Duan E; Song H; Xu Y; SenGupta D; Tandon R; Sacha JB; Brockman MA; Benko E; Kovacs C; Nixon DF; Ostrowski MA
J Clin Invest; 2012 Dec; 122(12):4473-89. PubMed ID: 23143309
[TBL] [Abstract][Full Text] [Related]
10. Identification of the protease cleavage sites in a reconstituted Gag polyprotein of an HERV-K(HML-2) element.
George M; Schwecke T; Beimforde N; Hohn O; Chudak C; Zimmermann A; Kurth R; Naumann D; Bannert N
Retrovirology; 2011 May; 8():30. PubMed ID: 21554716
[TBL] [Abstract][Full Text] [Related]
11. Human endogenous retrovirus HERV-K(HML-2) Rec expression and transcriptional activities in normal and rheumatoid arthritis synovia.
Ehlhardt S; Seifert M; Schneider J; Ojak A; Zang KD; Mehraein Y
J Rheumatol; 2006 Jan; 33(1):16-23. PubMed ID: 16395745
[TBL] [Abstract][Full Text] [Related]
12. Human endogenous retrovirus K (HML-2) RNA and protein expression is a marker for human embryonic and induced pluripotent stem cells.
Fuchs NV; Loewer S; Daley GQ; Izsvák Z; Löwer J; Löwer R
Retrovirology; 2013 Oct; 10():115. PubMed ID: 24156636
[TBL] [Abstract][Full Text] [Related]
13. Identification of differentially expressed HERV-K(HML-2) loci in colorectal cancer.
Kang Q; Guo X; Li T; Yang C; Han J; Jia L; Liu Y; Wang X; Zhang B; Li J; Wen HL; Li H; Li L
Front Microbiol; 2023; 14():1192900. PubMed ID: 37342563
[TBL] [Abstract][Full Text] [Related]
14. The human endogenous retrovirus family HERV-K(HML-3).
Mayer J; Meese EU
Genomics; 2002 Sep; 80(3):331-43. PubMed ID: 12213204
[TBL] [Abstract][Full Text] [Related]
15. Human Endogenous Retroviruses Long Terminal Repeat Methylation, Transcription, and Protein Expression in Human Colon Cancer.
Dolci M; Favero C; Toumi W; Favi E; Tarantini L; Signorini L; Basile G; Bollati V; D'Alessandro S; Bagnoli P; Ferrante P; Delbue S
Front Oncol; 2020; 10():569015. PubMed ID: 33194657
[TBL] [Abstract][Full Text] [Related]
16. Human endogenous retrovirus family HERV-K(HML-2) RNA transcripts are selectively packaged into retroviral particles produced by the human germ cell tumor line Tera-1 and originate mainly from a provirus on chromosome 22q11.21.
Ruprecht K; Ferreira H; Flockerzi A; Wahl S; Sauter M; Mayer J; Mueller-Lantzsch N
J Virol; 2008 Oct; 82(20):10008-16. PubMed ID: 18684837
[TBL] [Abstract][Full Text] [Related]
17. Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.
Flockerzi A; Ruggieri A; Frank O; Sauter M; Maldener E; Kopper B; Wullich B; Seifarth W; Müller-Lantzsch N; Leib-Mösch C; Meese E; Mayer J
BMC Genomics; 2008 Jul; 9():354. PubMed ID: 18664271
[TBL] [Abstract][Full Text] [Related]
18. Increased HERV-K(HML-2) Transcript Levels Correlate with Clinical Parameters of Liver Damage in Hepatitis C Patients.
Weber M; Padmanabhan Nair V; Bauer T; Sprinzl MF; Protzer U; Vincendeau M
Cells; 2021 Mar; 10(4):. PubMed ID: 33807462
[TBL] [Abstract][Full Text] [Related]
19. Haplotype analysis of the human endogenous retrovirus locus HERV-K(HML-2.HOM) and its evolutionary implications.
Mayer J; Stuhr T; Reus K; Maldener E; Kitova M; Asmus F; Meese E
J Mol Evol; 2005 Nov; 61(5):706-15. PubMed ID: 16211423
[TBL] [Abstract][Full Text] [Related]
20. HERV-K(HML-2) GAG/ENV antibodies as indicator for therapy effect in patients with germ cell tumors.
Kleiman A; Senyuta N; Tryakin A; Sauter M; Karseladze A; Tjulandin S; Gurtsevitch V; Mueller-Lantzsch N
Int J Cancer; 2004 Jun; 110(3):459-61. PubMed ID: 15095315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
